Essential fatty acids: Theoretical aspects and treatment implications for schizophrenia and depression

Advances in Psychiatric Treatment

Volumn 8, Issue 3, 2002, Pages 223-229

  Peet, Malcolm ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ARACHIDONIC ACID; CLOZAPINE; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; NEUROLEPTIC AGENT; NEUROTRANSMITTER RECEPTOR; NICOTINIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; PLACEBO; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

AFFECTIVE NEUROSIS; ARTICLE; CONTROLLED STUDY; DEPRESSION; DIET SUPPLEMENTATION; DIET THERAPY; DISEASE ASSOCIATION; FAT INTAKE; FATTY ACID METABOLISM; FLUSHING; FOOD INTAKE; HEART DISEASE; HUMAN; INFLAMMATION; LIFESTYLE; MANIC DEPRESSIVE PSYCHOSIS; MENTAL HEALTH; NEUROMODULATION; NEUROTRANSMISSION; PHOSPHOLIPID METABOLISM; PHOSPHOLIPID SYNTHESIS; SCHIZOPHRENIA; SEA FOOD; TARDIVE DYSKINESIA;

EID: 0036267242     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.8.3.223     Document Type: Article

References (30)

1. Fat consumption and schizophrenia
2. Effects on plasma lipoproteins and hypertriglyceridemic patients
3. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients
4. Omega-3 fatty acid and schizophrenia: A randomised trial of ethyl-eicosapentaenoic acid (ethyl-EPA) versus placebo as add-on treatment
5. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia
6. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia
7. Clozapine, diabetes mellitus, weight gain and lipid abnormalities: A five year naturalistic study
8. Fish consumption and major depression
9. Seafood consumption, the DHA content of mother's milk and prevalence rates of postpartum depression: A cross-national, ecological analysis
10. The positive and negative syndrome scale (PANSS) for schizophrenia
11. Magnetic resonance spectroscopy in schizophrenia: Methodological issues and findings - Part II
12. A double-blind placebo-controlled study of decosahaexanoic acid in the treatment of depression
13. Schizophrenic symptoms and dietary intake of n3 fatty acids
14. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder
15. At issue: Schizophrenia and rheumatoid arthritis: The negative association revisited
16. A dose-ranging study of ethyl-eicosapentonoate in treatment-unresponsive depression
17. A dose-ranging exploratory study of the effects of ethyl-eicosapentonate in patients with persistent schizophrenic symptoms
18. Arachidonic acid: A common link in the biology of schizophrenia?
19. Depleted red cell membrane essential fatty acids in drug treated schizophrenic patients
20. Two double blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia
21. Depression and cardiac mortality: Results from a community based longitudinal study
22. Eicosapentaenoic acid treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neural membrane phospholipid turnover and structural brain changes
23. Differential alteration of phospholipase A2 activities in brains of patients with schizophrenia
24. Physical exercise and psychological well-being: A critical review
25. Omega-3 fatty acids in bipolar disorder: A preliminary double blind, placebo controlled trial
26. Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient
27. Fish consumption and depressive symptoms in the general population in Finland
28. The South London and Maudsley NHS Trust 2001 Prescribing Guidelines
29. Niacin skin flush in schizophrenia: A preliminary report
30. Retinal function as a marker for cell membrane omega-3 fatty acid depletion in schizophrenia: A pilot study